Major Chest Procedures without CC/MCC DRG Reimbursement

DRG 165 encompasses major chest procedures without a Complication or Comorbidity or Major Complication or Comorbidity, covering significant thoracic resections and related surgeries. This Diagnosis-Related Group is important for inpatient reimbursement because it defines payment for high-resource thoracic operations under Centers for Medicare & Medicaid Services Medicare rules.

DRG 165 Overview

DRG 165 covers major chest procedures without a Complication or Comorbidity or Major Complication or Comorbidity. It includes inpatient stays for significant thoracic surgical interventions such as lobectomy, pneumonectomy, and other major resections when no CC or MCC is coded. This Diagnosis-Related Group matters because it groups cases with substantial resource use into a payment category used by the Centers for Medicare & Medicaid Services for Medicare inpatient reimbursement. Accurate coding of procedures and comorbid conditions determines assignment to this Diagnosis-Related Group and impacts hospital payment.

Acute perioperative intervention studies evaluating techniques to reduce intraoperative morbidity and short-term complications in patients undergoing major chest procedures (such as thoracotomy, lobectomy, or esophagectomy) without complicating comorbid conditions. These trials enroll adult surgical patients in the operating room and immediate postoperative period to test optimized anesthesia protocols, blood-sparing strategies, enhanced recovery pathways, or minimally invasive approaches versus standard care. Results inform clinicians about immediate safety and efficacy differences and help payers anticipate resource use, length of stay, and complication-related costs for this DRG.
Comparative effectiveness trials comparing surgical approaches or perioperative care bundles in relatively uncomplicated major chest procedure cases to determine which strategies best reduce hospital length of stay and readmission. These studies typically randomize patients fit for major chest surgery without CC/MCC to techniques such as open versus video-assisted procedures, different chest tube management protocols, or standardized physiotherapy regimens. Findings guide providers on practice patterns that optimize short-term outcomes and allow payers to evaluate value-based reimbursement models tied to efficient, high-quality inpatient care.
Post-discharge outcomes and health services research following patients who had major chest procedures without CC/MCC to measure functional recovery, late complications (e.g., persistent air leak, surgical site issues), and health-related quality of life over 30–90 days. Cohort studies or pragmatic trials assess how discharge planning, home health services, and early outpatient follow-up affect rehospitalization and patient-reported outcomes in a lower-complexity surgical cohort. This research is relevant to care managers and payers because it identifies interventions that reduce costly readmissions and improve transitions of care for beneficiaries captured under DRG 165.

Acute perioperative intervention studies evaluating techniques to reduce intraoperative morbidity and short-term complications in patients undergoing major chest procedures (such as thoracotomy, lobectomy, or esophagectomy) without complicating comorbid conditions. These trials enroll adult surgical patients in the operating room and immediate postoperative period to test optimized anesthesia protocols, blood-sparing strategies, enhanced recovery pathways, or minimally invasive approaches versus standard care. Results inform clinicians about immediate safety and efficacy differences and help payers anticipate resource use, length of stay, and complication-related costs for this DRG.
Comparative effectiveness trials comparing surgical approaches or perioperative care bundles in relatively uncomplicated major chest procedure cases to determine which strategies best reduce hospital length of stay and readmission. These studies typically randomize patients fit for major chest surgery without CC/MCC to techniques such as open versus video-assisted procedures, different chest tube management protocols, or standardized physiotherapy regimens. Findings guide providers on practice patterns that optimize short-term outcomes and allow payers to evaluate value-based reimbursement models tied to efficient, high-quality inpatient care.
Post-discharge outcomes and health services research following patients who had major chest procedures without CC/MCC to measure functional recovery, late complications (e.g., persistent air leak, surgical site issues), and health-related quality of life over 30–90 days. Cohort studies or pragmatic trials assess how discharge planning, home health services, and early outpatient follow-up affect rehospitalization and patient-reported outcomes in a lower-complexity surgical cohort. This research is relevant to care managers and payers because it identifies interventions that reduce costly readmissions and improve transitions of care for beneficiaries captured under DRG 165.

OpenPayer

Summary & Overview

Major Chest Procedures without CC/MCC: Inpatient Reimbursement Overview

DRG 165 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes